Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
Breast Cancer
FDA: Men Should Be Included in Breast Cancer Clinical Trials
Draft guidance that men be included in breast cancer trials issued by the FDA.
AI Program May Aid in Pathologic Evaluation of Breast Biopsies
Computer-based automated approach promising for differentiating ductal carcinoma in situ from atypia
AI Assists in Reading of Digital Breast Tomosynthesis Images
Concurrent use of AI system improves cancer detection, reduces reading time and recall rate.
Effects of Total Cumulative and Early vs Late Dose Reductions in FEC-D for Early Stage Breast Cancer
In this retrospective study, researchers sought to determine the survival impact of reductions in total cumulative dose and early vs late dose reductions of third-generation adjuvant chemotherapy regimens in patients with early-stage breast cancer.
Rozlytrek, a Tumor Agnostic Therapy, Receives FDA Approval
The Food and Drug Administration (FDA) has granted accelerated approval to Rozlytrek (entrectinib; Genentech)
Beef or Chicken: Examining How Meat Intake Affects Breast Cancer Risk
Researchers examined the link between consuming different types of meat and the incidence of invasive breast cancer. We review their findings.
Red Meat Consumption May Up Risk of Invasive Breast Cancer
Findings from prospective cohort study of sisters or half-sisters of women diagnosed with breast cancer.
Beliefs Held by Breast Surgeons That Impact the Treatment Decision Process for Advanced Breast Cancer Patients: A Qualitative Study
[Breast Cancer: Targets and Therapy] A series of semi-structured interviews with breast specialists revealed how surgeons’ own beliefs regarding patients’ ability to accept death influenced how they managed treatment decision making.
Delay in Time to Chemotherapy Impacts Survival in Breast Cancer
Time interval from diagnosis to surgery has largest impact on time from diagnosis to chemo initiation.
Next post in Breast Cancer
